Post-earnings recap
Reported
Thu, Apr 25, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Teladoc Health's first quarter results showed a loss that was slightly worse than expected, leading to a 2.91% drop in stock price. The lack of revenue data and forward guidance adds uncertainty for investors. Management's focus on cost management suggests they are preparing for a challenging market ahead.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.49 | N/A | -3.38% |
Management expressed concerns about the competitive landscape and its impact on growth. They are prioritizing cost control measures to navigate these challenges.
Management acknowledged ongoing challenges in the current market environment.
They emphasized a focus on cost management and operational efficiency.